MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMDXG
āļāļ·āđāļāļāļĢāļīāļĐāļąāļMiMedx Group Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 20, 2007
āļāļĩāļāļĩāđāļCapper (Joseph H)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ837
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļAug 20
āļāļĩāđāļāļĒāļđāđ1775 W Oak Commons Court, Ne
āđāļĄāļ·āļāļMARIETTA
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ30062
āđāļāļĢāļĻāļąāļāļāđ17706519100
āđāļ§āđāļāđāļāļāđhttps://mimedx.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMDXG
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 20, 2007
āļāļĩāļāļĩāđāļCapper (Joseph H)
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. James L. Bierman
Independent Director
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Ms. Dorothy E. Puhy
Independent Director
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Independent Director
Mr. Douglas C. Rice
Chief Financial Officer
Mr. K. Todd Newton
Independent Director
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. James L. Bierman
Independent Director
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Ms. Dorothy E. Puhy
Independent Director
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Invesco NASDAQ Future Gen 200 ETF
Janus Henderson Small Cap Growth Alpha ETF
First Trust Small Cap Growth AlphaDEX Fund
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Franklin US Small Cap Multifactor Index ETF
Vanguard US Quality Factor ETF
WisdomTree US SmallCap Quality Growth Fund
VictoryShares Small Cap Free Cash Flow ETF
State Street SPDR S&P Biotech ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļāļŠāđāļ§āļ0.58%
Janus Henderson Small Cap Growth Alpha ETF
āļŠāļąāļāļŠāđāļ§āļ0.56%
First Trust Small Cap Growth AlphaDEX Fund
āļŠāļąāļāļŠāđāļ§āļ0.3%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.17%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.16%
Franklin US Small Cap Multifactor Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.15%
Vanguard US Quality Factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.14%
WisdomTree US SmallCap Quality Growth Fund
āļŠāļąāļāļŠāđāļ§āļ0.14%
VictoryShares Small Cap Free Cash Flow ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
State Street SPDR S&P Biotech ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ